Cargando…

Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer

Tumor infiltrating lymphocytes (TIL), which represent host adaptive response to the tumor, were first identified at scanning magnification to select areas with the highest counts on hematoxylin and eosin slides, quantitated per high-power field (HPF), and analyzed for association with recurrence-fre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jimenez-Rodriguez, Rosa M., Patil, Sujata, Keshinro, Ajaratu, Shia, Jinru, Vakiani, Efsevia, Stadler, Zsofia, Segal, Neil H., Yaeger, Rona, Konishi, Tsuyoshi, Shimada, Yoshifumi, Widmar, Maria, Wei, Iris, Pappou, Emmanouil, Smith, J. Joshua, Nash, Garrett, Paty, Philip, Garcia-Aguilar, Julio, Weiser, Martin R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671050/ https://www.ncbi.nlm.nih.gov/pubmed/33235819 http://dx.doi.org/10.1080/2162402X.2020.1841948

Ejemplares similares

Intratumoral T-cell repertoires in DNA mismatch repair-proficient and -deficient colon tumors containing high or low numbers of tumor-infiltrating lymphocytes
por: Kim, Jin K., et al.
Publicado: (2022)

Contemporary Validation of a Nomogram Predicting Colon Cancer Recurrence, Revealing All-Stage Improved Outcomes
por: Konishi, Tsuyoshi, et al.
Publicado: (2019)

Retained Mismatch Repair Protein Expression Occurs in Approximately 6% of Microsatellite Instability-High Cancers and is Associated with Missense Mutations in Mismatch Repair Genes.
por: Hechtman, Jaclyn F., et al.
Publicado: (2019)

Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal Cancer
por: Kim, Jin K, et al.
Publicado: (2022)

Recurrent, truncating SOX9 mutations are associated with SOX9 overexpression, KRAS mutation, and TP53 wild type status in colorectal carcinoma
por: Javier, Breanna M., et al.
Publicado: (2016)

Advances in the treatment of locally advanced rectal cancer
por: Ali, Fadwa, et al.
Publicado: (2020)

Quality of life and function after rectal cancer surgery with and without sphincter preservation
por: Pappou, Emmanouil P., et al.
Publicado: (2022)

Comparing outcomes of robotic versus open mesorectal excision for rectal cancer
por: Jimenez-Rodriguez, Rosa M, et al.
Publicado: (2022)

Erratum to: Comparing outcomes of robotic versus open mesorectal excision for rectal cancer
por: Jimenez-Rodriguez, Rosa M., et al.
Publicado: (2022)

Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions
por: Brannon, A Rose, et al.
Publicado: (2014)

Local recurrences at the anastomotic area are clonally related to the primary tumor in sporadic colorectal carcinoma
por: Vakiani, Efsevia, et al.
Publicado: (2017)

Feasibility of Organ Preservation With Short Course Radiation Therapy as Part of Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer During the COVID-19 Pandemic
por: Sarkar, R.R., et al.
Publicado: (2021)

Pathological Evaluation of Rectal Cancer Specimens Using Micro-Computed Tomography
por: Yoshida, Masao, et al.
Publicado: (2022)

Immunoscore in mismatch repair‐proficient and ‐deficient colon cancer
por: Wirta, Erkki‐Ville, et al.
Publicado: (2017)

Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers
por: Chatila, Walid K., et al.
Publicado: (2023)

Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery
por: Weiser, Martin R., et al.
Publicado: (2021)

A Dynamic Clinical Calculator for Estimating Conditional Recurrence-Free Survival After Total Neoadjuvant Therapy for Rectal Cancer and Either Surgery or Watch-and-Wait Management
por: Weiser, Martin R., et al.
Publicado: (2022)

Oncogenic KRAS activates an embryonic stem cell-like program in human colon cancer initiation
por: Le Rolle, Anne-France, et al.
Publicado: (2016)

Photodynamic therapy of DNA mismatch repair-deficient and -proficient tumour cells
por: Schwarz, V A, et al.
Publicado: (2002)

The prognostic significance of CXCL1 hypersecretion by human colorectal cancer epithelia and myofibroblasts
por: le Rolle, Anne-France, et al.
Publicado: (2015)

Robust Glycogene-Based Prognostic Signature for Proficient Mismatch Repair Colorectal Adenocarcinoma
por: Li, Yixi, et al.
Publicado: (2021)

Risk for Hereditary Neoplastic Syndromes in Women with Mismatch Repair-Proficient Endometrial Cancer
por: dos Santos, Jennifer Thalita Targino, et al.
Publicado: (2023)

Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer
por: Eppenberger, Manuela, et al.
Publicado: (2010)

Characterisation of the oxysterol metabolising enzyme pathway in mismatch repair proficient and deficient colorectal cancer
por: Swan, Rebecca, et al.
Publicado: (2016)

Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer
por: Konstantinopoulos, Panagiotis A., et al.
Publicado: (2022)

Immuno-Contexture and Immune Checkpoint Molecule Expression in Mismatch Repair Proficient Colorectal Carcinoma
por: Giacomelli, Mauro, et al.
Publicado: (2023)

Retroileal colorectal anastomosis after left-sided or transverse colectomy for advanced serous carcinoma of the ovary or uterus
por: Moukarzel, Lea A., et al.
Publicado: (2021)

Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells
por: Nehmé, A, et al.
Publicado: (1999)

Comparison of immunological characteristics between paired mismatch repair-proficient and -deficient colorectal cancer patients
por: Liu, Shou-Sheng, et al.
Publicado: (2018)

Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers
por: Hale, Vanessa L., et al.
Publicado: (2018)

Efficient engineering of chromosomal ribosome binding site libraries in mismatch repair proficient Escherichia coli
por: Oesterle, Sabine, et al.
Publicado: (2017)

Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer
por: Kasi, Pashtoon Murtaza, et al.
Publicado: (2023)

IGSF6 is a novel biomarker to evaluate immune infiltration in mismatch repair-proficient colorectal cancer
por: Rong, Yu-ming, et al.
Publicado: (2023)

Acquired resistance to immunotherapy in MMR-D pancreatic cancer
por: Hu, Zishuo Ian, et al.
Publicado: (2018)

Microsatellite stability and mismatch repair proficiency in nasopharyngeal carcinoma may not predict programmed death-1 blockade resistance
por: Liao, Xiyi, et al.
Publicado: (2017)

BRD4 inhibition impairs DNA mismatch repair, induces mismatch repair mutation signatures and creates therapeutic vulnerability to immune checkpoint blockade in MMR-proficient tumors
por: Fu, Yu, et al.
Publicado: (2023)

Survival of Patients with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal Cancer Receiving Curative-Intent Local Treatment of Metastases in a Nationwide Cohort
por: Zwart, Koen, et al.
Publicado: (2023)

Targeted next-generation sequencing of colorectal cancer identified metastatic specific genetic alterations
por: Brannon, A Rose, et al.
Publicado: (2012)

Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer
por: Zhou, Guoying, et al.
Publicado: (2018)

Dendritic cell paucity in mismatch repair–proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy
por: Ho, William W., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e4jr2o8s85sm1v3ae67qrh5fb9